Intuitive Surgical, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2025: USD 2.95 B

Intuitive Surgical, Inc. EBITDA is USD 2.95 B for the Trailing 12 Months (TTM) ending March 31, 2025, a 30.16% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Intuitive Surgical, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 2.27 B, a 15.72% change year over year.
  • Intuitive Surgical, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 1.96 B, a -8.09% change year over year.
  • Intuitive Surgical, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 2.13 B, a 45.74% change year over year.
  • Intuitive Surgical, Inc. EBITDA for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 1.46 B, a -10.27% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)